Expression of ATP-Insensitive KATP Channels in Pancreatic β-Cells Underlies a Spectrum of Diabetic Phenotypes
- From the Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri
- Address correspondence and reprint requests to C.G. Nichols, Department of Cell Biology and Physiology, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO 63110. E-mail: cnichols{at}cellbiology.wustl.edu
Abstract
Glucose metabolism in pancreatic β-cells elevates cytoplasmic [ATP]/[ADP], causing closure of ATP-sensitive K+ channels (KATP channels), Ca2+ entry through voltage-dependent Ca2+ channels, and insulin release. Decreased responsiveness of KATP channels to the [ATP]/[ADP] ratio should lead to decreased insulin secretion and diabetes. We generated mice expressing KATP channels with reduced ATP sensitivity in their β-cells. Previously, we described a severe diabetes, with nearly complete neonatal lethality, in four lines (A–C and E) of these mice. We have now analyzed an additional three lines (D, F, and G) in which the transgene is expressed at relatively low levels. These animals survive past weaning but are glucose intolerant and can develop severe diabetes. Despite normal islet morphology and insulin content, islets from glucose-intolerant animals exhibit reduced glucose-stimulated insulin secretion. The data demonstrate that a range of phenotypes can be expected for a reduction in ATP sensitivity of β-cell KATP channels and provide models for the corollary neonatal diabetes in humans.
- GFP, green fluorescence protein
- GSIS, glucose-stimulated insulin secretion
- GTT, glucose tolerance test
- HFD, high-fat diet
- KATP channel, ATP-sensitive K+ channel
- NDM, neonatal diabetes mellitus
- RIP I, rat insulin promoter I
Footnotes
-
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Accepted August 15, 2006.
- Received May 27, 2006.
- DIABETES














